Haemonetics to Buy Assets of Pall, Hemerus Medical

(Corrects to show two transactions.)

Haemonetics Corp. (HAE) said it agreed to acquire the blood collection and filtration assets of Pall Corp. (PAL) for approximately $551 million, and separately agreed to buy certain assets of Hemerus Medical LLC, a Minnesota-based company that develops technologies for the collection of whole blood, and processing and storage of blood components.

Haemonetics agreed to pay Pall $551 million, of which $536 million will be paid upon closing and the remaining $15 million paid for additional assets to be delivered by 2016, the statement said. Haemonetics said $475 million will be new borrowings and $61 million will be from existing cash holdings.

Haemonetics did not disclose the purchase price for the property of Hemerus.

To contact the editor responsible for this story: Theo Mullen at tmullen11@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.